COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 2431: Articles 24301-24310  | Next

Estimating the burden of COVID-19 on mortality, life expectancy and lifespan inequality in England and Wales: A population-level study
Aburto, J. M., Kashyap, R., Scholey, J., Angus, C., Ermisch, J., Mills, M., Dowd, J. B.
10.1101/2020.07.16.20155077 — Posted: 2020-07-16 Discussion: Offsite
SARS-COV-2 THREE FORCING SEASONALITIES: POLICIES, ENVIRONMENT AND URBAN SPACES
Telles, C. R.
10.1101/2020.07.15.20154823 — Posted: 2020-07-16
The impact of host resistance on cumulative mortality and the threshold of herd immunity for SARS-CoV-2
Lourenco, J., Pinotti, F., Thompson, C., Gupta, S.
10.1101/2020.07.15.20154294 — Posted: 2020-07-16 Discussion: Onsite
Projecting the second outbreaks for global COVID-19 pandemic
Huang, J., Liu, X., Zhang, L., Yang, K., Chen, Y., Huang, Z., Liu, C., Lian, X., Wang, D.
10.1101/2020.07.15.20154161 — Posted: 2020-07-16
Neurological manifestations associated with COVID-19: a nationwide registry
Meppiel, E., Peiffer-Smadja, N., Maury, A., Bekri, I., Delorme, C., Desestret, V., Gorza, L., Hautecloque-Raysz, G., Landre, S., Lannuzel, A., Moulin, S., Perrin, P., Petitgas, P., Sellal, F., Wang, A., Tattevin, P., de Broucker, T., contributors to the NeuroCOVID registry
10.1101/2020.07.15.20154260 — Posted: 2020-07-16 Discussion: Offsite
Characterization of the SARS-CoV-2 outbreak in the State of Qatar, February 28-April 18, 2020
Butt, A. A.
10.1101/2020.07.15.20154211 — Posted: 2020-07-16
The S1 protein of SARS-CoV-2 crosses the blood-brain barrier: Kinetics, distribution, mechanisms, and influence of ApoE genotype, sex, and inflammation
Rhea, E. M., Logsdon, A. F., Hansen, K. M., Williams, L., Reed, M., Baumann, K., Holden, S., Raber, J., Banks, W. A., Erickson, M. A.
10.1101/2020.07.15.205229 — Posted: 2020-07-15
A direct RNA-protein interaction atlas of the SARS-CoV-2 RNA in infected human cells
Schmidt, N., Lareau, C. A., Keshishian, H., Melanson, R., Zimmer, M., Kirschner, L., Ade, J., Werner, S., Caliskan, N., Lander, E. S., Vogel, J., Carr, S. A., Bodem, J., Munschauer, M.
10.1101/2020.07.15.204404 — Posted: 2020-07-15
Prophylactic and Therapeutic Inhibition of In Vitro SARS-CoV-2 Replication by Oleandrin
Plante, K. S., Plante, J. A., Fernandez, D., Mirchandani, D., Bopp, N. E., Aguilar, P. V., Sastry, K. J., Newman, R. A., Weaver, S. C.
10.1101/2020.07.15.203489 — Posted: 2020-07-15 Discussion: Onsite
The Effect Of Famotidine On SARS-CoV-2 Proteases And Virus Replication
Loffredo, M., Lucero, H., Chen, D.-Y., O'Connell, A., Bergqvist, S., Munawar, A., Bandara, A., DeGraef, S., Weeks, S. D., Douam, F., Saeed, M., Munawar, A. H.
10.1101/2020.07.15.203059 — Posted: 2020-07-15 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).